Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 22, 2021
Seqens CDMO, a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, announced that Bob Huang has joined as Managing Director for North America. The company is a ...
read more
Thursday, October 14, 2021
Pace Analytical Life Sciences® announced that it has acquired Velesco Pharmaceutical Services, Inc. Velesco, also a CDMO, specializes in liquid, semi-solid, and oral solid dose product development.
read more
OncoZenge AB has engaged Meribel Pharma Solutions (formerly Recipharm) as its Contract Development and Manufacturing Organization (CDMO) for the BupiZenge™ Phase 3 Project.
read more
Wednesday, September 18, 2019
One Drop announced $40 million in Series B financing, led by pharmaceutical company, Bayer.
read more
Phlow Corp. and Antheia announced an ongoing partnership to onshore production of essential medicines and establish more efficient, agile, and resilient pharmaceutical supply chains in the United States.
read more
MedPharm has expanded its innovative testing models to support pharmaceutical development programs targeting Coronavirus treatments.
read more
Friday, September 23, 2016
Medoc, a provider of neuro-diagnostic medical systems, has announced its official expansion from supporting academic research to serving the needs of Clinical Research Organizations, yielding improved success probabilities of pharmaceutical clinical ...
read more
SGS Life Science Services announced today the grand opening of its Fairfield, NJ facility, having just completed a major renovation that involved doubling the size of facility, investing in new, increased laboratory space, expanded client ...
read more
CPhI Worldwide, organised by UBM Live, and CPhI Pharma Evolution have announced its full expert industry panel list ahead of the publication of a forward looking annual report (due out in September) examining future contingencies for the ...
read more
Ligand Pharmaceuticals has entered into a worldwide license agreement with Cambridge, Massachusetts-based Surface Oncology.
read more
Mayne Pharma Inc., has announced that the U.S. Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for doxycycline hyclate immediate release (IR) tablets (75 mg and 150 mg). Mayne Pharma has ...
read more
Kymos and Prolytic GmbH announced the completion of a successful strategic merger to integrate Prolytic into the Kymos Group.
read more
Friday, February 12, 2021
AzurRx BioPharma has entered into an agreement with PPD for its trial evaluating micronized niclosamide for COVID-19-associated GI infections.
read more
Clinical ink announced the appointment of Andrew Kraus as Chief Technology Officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials.
read more
Evotec AG has been awarded a grant for a period of two years from IFB Hamburg to identify and develop therapeutic antibodies directed against novel immune-checkpoints on T-cells to improve future cancer treatments.
read more